Nobel Award Honors Groundbreaking Body's Defenses Discoveries

The Nobel Prize in Physiology or Medicine has been granted for transformative findings that clarify how the body's defense network attacks dangerous pathogens while sparing the healthy tissues.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—share this accolade.

The research uncovered unique "security guards" within the defense system that eliminate rogue immune cells capable of harming the body.

The discoveries are now paving the way for new treatments for immune disorders and cancer.

The laureates will share a monetary award valued at 11m SEK.

Crucial Discoveries

"The work has been essential for comprehending how the immune system operates and the reason we don't all suffer from severe self-attack conditions," stated the head of the award panel.

The team's studies explain a core mystery: How does the defense system defend us from numerous infections while leaving our own tissues intact?

Our immune system uses immune cells that search for signs of disease, even viruses and germs it has never encountered.

These cells employ sensors—called recognition units—that are generated randomly in a vast number of combinations.

That gives the immune system the capacity to fight a broad range of invaders, but the randomness of the process unavoidably creates immune cells that can target the host.

Security Guards of the Immune System

Researchers previously knew that a portion of these harmful white blood cells were destroyed in the immune organ—where white blood cells mature.

This year's award recognizes the discovery of regulatory T-cells—described as the body's "security guards"—which patrol the system to neutralize other defenders that attack the healthy cells.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "These findings have established a new field of research and accelerated the creation of innovative therapies, for instance for cancer and autoimmune diseases."

Regarding malignancies, T-regs block the system from attacking the tumor, so studies are aimed at reducing their numbers.

In self-attack disorders, trials are testing increasing regulatory T-cells so the body is no longer being harmed. A similar approach could also be effective in reducing the risks of organ transplant rejection.

Innovative Experiments

Professor Sakaguchi, of a Japanese institution, conducted tests on rodents that had their immune gland removed, causing self-attack conditions.

He showed that injecting defense cells from healthy mice could prevent the disease—implying there was a mechanism for blocking defenders from attacking the host.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic autoimmune disease in mice and humans that resulted in the discovery of a gene critical for how T-regs operate.

"The groundbreaking research has uncovered how the body's defenses is controlled by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," said a prominent physiology specialist.

"The research is a remarkable illustration of how basic biological research can have broad consequences for human health."